CurrentEndo
Get Weekly

Topic · page 40 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 1,561–1,600 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

  1. Endocr Pract

    Empowering Diabetes Care Through Pharmacist-Led Education: A Randomized Controlled Trial in a Low-Resource Setting

    Randomized controlled trial

  2. Diabetes Res Clin Pract

    Impact of SGLT2 inhibitors on kidney health and survival in patients with polycystic kidney disease and type 2 diabetes

    Cohort study

  3. Diabetologia

    Inflammatory markers and blood glucose are higher after morning vs afternoon exercise in type 2 diabetes

    Randomized controlled trial

  4. Int J Obes (Lond)

    Are low carbohydrate diet interventions beneficial for metabolic syndrome and its components? A systematic review and meta-analysis of randomized controlled trials

    Meta-analysis

  5. Diabetologia

    Diabetogenic elevated childhood total fat in South Asian and Black African/Caribbean people relates to adverse early life growth and low socioeconomic position compared with White people in the UK

    Secondary analysis

  6. Diabetes Care

    Impaired Rest–Activity Rhythm Characteristics Predict Higher Risk of Incident Type 2 Diabetes in UK Biobank Participants

    Cohort study

  7. Diabetes Care

    Glucagon-Like Peptide 1 Receptor Agonists and the Risk of Emergency Department Visits and Hospitalization in Patients With Chronic Kidney Disease

    Cohort study

  8. Diabetes Res Clin Pract

    Clinical outcomes in people with type 2 diabetes and acute kidney disease: combined SGLT2i and GLP-1RA therapy vs. monotherapy

    Cohort study

  9. J Clin Endocrinol Metab

    Plasma Sphingolipids in Relation to Glycemia and Glucose Tolerance in People Without Diabetes

    Cross-sectional study

  10. Diabetes Obes Metab

    Blood glucose and body weight reduction for the prevention of clinical events and mortality in patients with type 2 diabetes: A meta‐analysis and meta‐regression of 44 randomized controlled trials

    Meta-analysis

  11. Diabetes Obes Metab

    Impact of baseline alanine aminotransferase levels on the efficacy of dapagliflozin and sitagliptin: Latent class analysis from the DIVERSITY ‐ CVR study

    Secondary analysis

  12. Diabetes Res Clin Pract

    Renal function and its association with retinal microcirculation and choroidal thickness in type 2 diabetes: Insights from cystatin C and creatinine

    Cross-sectional study

  13. Diabetes Res Clin Pract

    The utility of common predictive models for detecting undiagnosed diabetes and prediabetes defined by HbA1c in a Chinese population

    Cross-sectional study

  14. Diabetes Res Clin Pract

    Global burden of diabetes in reproductive-age women (1990–2021), with projections to 2045: Systematic analysis of the global burden of disease study 2021

    Cohort study

  15. Diabetes Care

    Differential Effect of GLP-1 Receptor Agonists and SGLT2 Inhibitors on Lower-Extremity Amputation Outcomes in Type 2 Diabetes: A Nationwide Retrospective Cohort Study

    Cohort study

  16. Diabetes Res Clin Pract

    Impact of cardiovascular risk visualization on motivation to self-manage young-onset type 2 diabetes

    Research article

  17. Diabetes Obes Metab

    PIONEER REAL Spain : A multicentre, prospective, real‐world study of oral semaglutide use in adults with type 2 diabetes

    Cohort study

  18. Diabetes Obes Metab

    Efficacy and safety of combination therapy using SGLT2 and DPP4 inhibitors to treat type 2 diabetes: An updated systematic review and meta‐analysis with focus on an Asian subpopulation

    Meta-analysis

  19. Diabetes Res Clin Pract

    Incidental hyperglycemia in women at reproductive age and its association with thyrotropin levels: A population-based cohort study in China

    Cohort study

  20. Diabetes Res Clin Pract

    Genetic determinants of variable anti-diabetic therapy responses across diverse populations with type 2 diabetes mellitus: a systematic review and meta-analysis

    Meta-analysis

  21. Diabetes Res Clin Pract

    Healthcare and prescription medication affordability in adults with diabetes in the United States, 2020–2023

    Cross-sectional study

  22. J Clin Endocrinol Metab

    Maturity-Onset Diabetes of the Young (MODY) in a Racially/Ethnically Diverse Pediatric Population

    Cohort study

  23. J Clin Endocrinol Metab

    Novel Inpatient Automated Self-Adjusting Subcutaneous Insulin Algorithm: 3-Year Experience. An Observational Study

    Cohort study

  24. Diabetes Res Clin Pract

    Mortality, kidney, and safety outcomes with SGLT2 inhibitors versus DPP4 inhibitors in patients with type 2 diabetes treated with systemic glucocorticoids: a real-world exploratory study

    Cohort study

  25. Diabetes Care

    Inadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone Treatment

    Randomized controlled trial

  26. J Clin Endocrinol Metab

    Multidimensional Pancreatic Islet β-cell Function Assessment Improves Predictive Effect of Diabetes Risk Scores

    Mechanistic study

  27. BMJ Open Diabetes Res Care

    Fasting plasma glucose outperformed 1-hour plasma glucose in predicting diabetes incidence in individuals with family history of young-onset type 2 diabetes

    Cohort study

  28. Lancet

    Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 2 diabetes currently treated with basal insulin (QWINT-3): a phase 3, randomised, non-inferiority trial

    Randomized controlled trial

  29. Lancet

    Once-weekly insulin efsitora alfa versus once-daily insulin glargine U100 in adults with type 2 diabetes treated with basal and prandial insulin (QWINT-4): a phase 3, randomised, non-inferiority trial

    Randomized controlled trial

  30. N Engl J Med

    Weekly Fixed-Dose Insulin Efsitora in Type 2 Diabetes without Previous Insulin Therapy

    Randomized controlled trial

  31. N Engl J Med

    Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes

    Randomized controlled trial

  32. Horm Res Paediatr

    ADECA: A novel course for training Paediatric Diabetes Nurse Educators in Sub-Saharan Africa

    Research article

  33. Diabetes Care

    Benefit of Semaglutide in Symptomatic Peripheral Artery Disease by Baseline Type 2 Diabetes Characteristics: Insights From STRIDE, a Randomized, Placebo-Controlled, Double-Blind Trial

    Secondary analysis

  34. J Diabetes Sci Technol

    Enhancing Mobile App Adoption for Type 2 Diabetes Mellitus Medication Adherence and Self-Management: A Grounded Theory Study

    Research article

  35. Endocr Pract

    Trajectories of Antidiabetic Medication Adherence in Older Adults and the Effect of Depression and Anxiety Symptoms

    Secondary analysis

  36. N Engl J Med

    Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes

    Randomized controlled trial

  37. Diabetes Care

    Sociodemographic, Clinical, and Psychosocial Predictors of Short- and Long-term Study Retention in the Diabetes Prevention Program (DPP) Outcomes Study (DPPOS)

    Secondary analysis

  38. Diabetes Res Clin Pract

    The association of weight status with glycemic control, diabetes related complications and anti-hyperglycemic medication use in patients with type 2 diabetes mellitus: The results of the Australian National Diabetes Audit (ANDA) 2015–2022

    Cross-sectional study

  39. Diabetes Res Clin Pract

    Associations of age at T2D detection with hemoglobin A1c in a national inception cohort of U.S. Veterans with diabetes

    Cohort study

  40. Diabetes Metab

    Mitochondrial heteroplasmy-phenotype correlation and response to glucose lowering therapy in subjects with m.3243A>G mutations

    Cohort study

All 4,758 Briefs in ExploreShowing Briefs 1,561–1,600 of 4,758, newest first